Tokyo, Nov. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059642) titled 'Evaluation of brain serotonin transporter in patients with chronic pain using central nervous system PET' on Nov. 5.
Study Type:
Observational
Primary Sponsor:
Institute - Nippon Medical School
Condition:
Condition - chronic pain
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Elucidation of basis for pain in the brain using evaluation of serotonin transporter in patients with chronic pain
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - patients with chronic pain
Key exclusion criteria - History of serious physical illness, organic brain disease, or seizure disorder
Unsuitable for the MRI environment, such as claustrophobia or wearing devices (cardiac pacemakers, cerebral artery clips, etc.) that are affected by MRI
Serious liver or kidney disorders or heart disease that could affect safety evaluation
Exposed to more than 15 mSv (millisieverts) of radiation per year due to work-related exposure or radiation therapy
Received contrast agents or radiopharmaceuticals within two days of the examination, or who are scheduled to receive such treatment the day after
Pregnant women or those who may be pregnant
Target Size - 30
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 02 Month 12 Day
Date of IRB - 2025 Year 02 Month 12 Day
Anticipated trial start date - 2025 Year 04 Month 01 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068223
Disclaimer: Curated by HT Syndication.
